ALP Bio
Last verified 2026-05-16. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.1Mattributed |
|---|---|
| Latest round | pre-seed, $2.1M, 2026-04-29attributed |
| Founded | 2025 |
| Headquarters | Schlieren |
| Industry | bio |
| Stage | pre-seed |
| Website | alpbio.ch |
alpbio.ch refused the connection at fetch time. Per the .bio site, ALP Bio runs immunogenicity assessment using tonsil organoids and protein AI. Targets biopharma teams predicting anti-drug antibody formation.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-29 | pre-seed | $2.1M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Pre-seed, $2.1M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $2.1M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | alpbio.ch, read 2026-05-16 |
| Description | self-reported | alpbio.ch, read 2026-05-16 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.